An protocol of ongoing trial by Mary ER et al[33] is available online, which assess the effect of pentoxifylline on adipocyte-derived cytokines, leptin and adiponectin, and its effect on free fatty acid levels in patients with NASH, but we was not able to find the final report. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.